Figure 4.
sGOT levels of steatotic OLT recipients. CS1-mediated blockade of α4β1-FN interactions improved liver function as evidenced by sGOT levels. Levels of sGOT were significantly lower at 6 hours (P < 0.04), day 3 (P < 0.02), and day 7 (P < 0.01) in the CS1 peptide-treated recipients as compared with respective controls (n = 4 to 5 rats/group).